ALSO NOTED: Esprit hands over drug; Diatos gins $12.8M; Swans dead of avian flu; and much more...

> Esprit Pharma has agreed to pay $15 million and return ownership of a urinary tract infection drug to Depomed. Report

> France's Diatos has raised $12.8 million in its fourth round of venture capital. Report

> There's new evidence to support the theory that the enzyme protein kinase G offers a promising target in the fight against tuberculosis. Report

And Finally…Three swans found dead in eastern France have tested positive for the H5N1 strain. Report

Suggested Articles

Bausch Health is paying $10 million upfront for the option to acquire Allegro Ophthalmics’ eye disease assets, with a promise of $40 million to come.

Anthony Coyle, Ph.D., has signed up to run Repertoire Immune Medicines’ R&D.

The IPO haul will set Kronos up to start a registrational phase 2/3 trial of a first-line AML drug licensed from Bischofberger's former employer.